The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Gray stressed the effects are quite modest and only really effective at the really early stages of Alzheimer’s disease (and don’t work for vascular dementia ... as three months. The most commonly ...

Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in ...

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...

CADASIL is a brain disease involving genetic mutations, stroke, and dementia. Learn about symptom progression and ongoing ...

A BMJ investigation found seven of the eight doctors appointed by the US Food & Drug Administration (FDA) to review donanemab ...

Artificial intelligence is to be used to tackle the most deadly parasitic diseases in the developing world, tech company ...

Researchers from DZNE and Otto von Guericke University Magdeburg have identified individuals with increased risk for dementia ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

Imagine youre sitting down with your loved one someone youve known for decades Yet lately you notice subtle changes They struggle with names forget familiar places and their once sharp personality see ...